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In higher eukaryotes, the condensin complex, which mainly consists of two
structural maintenance of chromosomes (SMC) subunits, SMC2 (CAP-E) and
SMC4 (CAP-C), plays a critical role in the formation of higher order
chromosome structures during mitosis. Biochemical and electron-microscopic
studies have revealed that the SMC2 and SMC4 subunits dimerize through the
interaction of their hinge domains, forming a characteristic V-shaped hetero-
dimer. However, the details of their function are still not fully understood owing
to a lack of structural information at the atomic level. In this study, the human
SMC2 hinge domain with short coiled coils was cloned, expressed, purified and
crystallized in the orthorhombic space group C222 in native and SeMet-
derivatized forms. Because of the poor diffraction properties of these crystals,
the mutant Leu68!SeMet was designed and crystallized in order to obtain the
experimental phases. The SeMet-derivatized crystals of the mutant belonged to
space group P3212, with unit-cell parameters a = b = 128.8, c = 91.4 Å. The
diffraction data obtained from a crystal that diffracted to 2.4 Å resolution were
suitable for SAD phasing.
1. Introduction
During mitosis, the formation of higher order structures of chromo-
somes is a critical event for the efficient transmission of genetic
information to daughter cells. In higher eukaryotes, it has been
revealed that a large multi-subunit protein complex called condensin
plays an important role in this process (Hirano, 2005). Our proteomic
analysis of human metaphase chromosomes confirmed that signifi-
cant amounts of condensin subunits were present in the metaphase
chromosome (Uchiyama et al., 2005; Fukui & Uchiyama, 2007). The
condensin complex is composed of two structural maintenance of
chromosomes (SMC) subunits, SMC2 (CAP-E) and SMC4 (CAP-C),
that form a heterodimer that interacts with three other non-SMC
subunits (Ono et al., 2003). In contrast, in prokaryotes there is only
one SMC subunit, which functions as a homodimer.
The overall architecture of the condensin complex was initially
revealed by electron-microscopy studies, which showed that each of
the SMC subunits is a 50 nm long rod-like antiparallel coiled coil with
a globular ATPase ‘head’ domain at one end and a ‘hinge’ domain at
the other end (Anderson et al., 2002). The two subunits are dimerized
through the hinge–hinge interaction, forming a V-shaped hetero-
dimer, and further interact with three non-SMC subunits at their
heads to form a lollipop-like closed-ring structure. Because of this
characteristic architecture, together with other biochemical studies,
it was believed that the chromosome is folded by the condensin
complex, trapping chromatin fibres inside the ring structure.
However, recent results have demonstrated that a biologically active
condensin complex which has been made cleavable at the coiled-coil
region of the SMC2 subunit does not alter the condensin association
or binding to chromosomes even when the subunit is cleaved on
the chromosomes (Hudson et al., 2008). Thus, the condensation of
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chromosomes by the complex may not require the topological closure
of the complex and shows the importance of its interaction with DNA
and/or other proteins, including other condensin complexes.
In this context, it is remarkable that direct interactions not only
between condensin complexes but also between the condensin
complex and DNA have been captured by atomic force microscopy
studies on purified fission yeast condensin (Yoshimura et al., 2002).
These studies indicated that binding of the condensin complex to
DNA might occur via its hinge domain, although the details of the
interaction are still elusive. Recently, the structure of the mouse
condensin SMC2–SMC4 hinge complex, which is the first eukaryotic
SMC hinge crystal structure, was reported by Hopfner and coworkers
(Griese et al., 2010). Although the complex structure clearly revealed
the complete structure of the SMC4 hinge, the C-terminal portion
of the SMC2 hinge was not identified owing to the short construct.
Consequently, this eliminates one of the two expected binding
surfaces and hampered complete description of the hinge–hinge and/
or hinge–DNA interactions.
As seen in the crystal structure of the Thermotoga maritima SMC
(TmSMC) hinge domain with short coiled coils at both the C-terminal
and N-terminal ends (PDB code 1gxl; Haering et al., 2002), it is
obvious that the hinge domain is stabilized by the interaction
between the coiled-coil regions that extend from both ends. There-
fore, in this study the hinge domain of human condensin SMC2
subunit with short coiled coils (hSMC-h-scc) was selected for cloning
and overexpression. The crystallization and preliminary X-ray
analyses of wild-type hSMC2-h-scc and several SeMet-substituted
hSMC2-h-scc mutants are reported here.
2. Materials and methods
2.1. Cloning, expression and purification
A DNA fragment encoding amino acids 476–707 of the human
SMC2 was amplified by PCR using full-length human SMC2 cDNA as
a template. This was then inserted into the pET48b(+) expression
vector (Invitrogen) between the XmaI and SalI restriction sites. The
recombinant plasmid was introduced into Escherichia coli strain
Rosetta2 (DE3) and the cell culture was grown at 310 K to an optical
density (OD660) of 0.6. The culture was rapidly cooled on ice and
protein expression was induced by adding isopropyl -d-1-thio-
galactopyranoside (IPTG) to a final concentration of 1 mM. After
further growth for 24 h at 283 K, the cells were harvested by centri-
fugation at 8000g for 10 min at 277 K, resuspended in lysis buffer
(50 mM Tris–HCl pH 8.0, 150 mM NaCl) and disrupted by ultra-
sonication on ice. The lysate was centrifuged at 48 400g for 30 min to
remove insoluble debris. All subsequent procedures were carried out
at 283 K unless stated otherwise. The supernatant was filtered and
loaded onto a HisTrap HP column (GE Healthcare) previously
equilibrated with lysis buffer. The protein was eluted with a gradient
of imidazole. The vector-encoded N-terminal His tag of the eluted
protein was cleaved using HRV3C protease (Takara Bio) for 48 h at
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Figure 1
Crystals of hSMC2-h-scc. (a) Ellipsoid-shaped crystals of wild-type hSMC2-h-scc. (b) Improved cubic crystals of wild-type hSMC2-h-scc. (c) Cubic crystal of SeMet-
substituted hSMC2-h-scc. (d) Hexagonal crystals of the Leu68!SeMet mutant of hSMC2-h-scc.
277 K during dialysis against lysis buffer. Complete cleavage was
achieved using a 1:1000(w:w) ratio of protease to target protein. The
protein was again loaded onto a HisTrap HP column to remove His-
tag-containing protein and was further purified by gel filtration on a
HiLoad 26/60 Superdex 75 column (GE Healthcare). The purity of
the protein was judged by SDS–PAGE analysis (data not shown).
SeMet-substituted hSMC2-h-scc was produced by introducing the
expression construct into the Met-requiring auxotrophic E. coli strain
B834 (DE3). SeMet-substituted hSMC2-h-scc was purified using the
same procedure as used for the wild-type protein. To obtain phase
information (see below), a Leu-to-SeMet mutation was additionally
introduced into SeMet-substituted hSMC2-h-scc. Five of the 30 Leu
residues were selected, i.e. Leu31, Leu66, Leu68, Leu74 and Leu188,
and their Leu!Met mutants were created. Site-directed mutagenesis
was performed with the QuikChange site-directed mutagenesis kit
(Stratagene) and SeMet-substituted proteins corresponding to each
Leu!Met mutant were individually expressed using the same
protocol as used for SeMet-substituted hSMC2-h-scc.
2.2. Crystallization
Wild-type hSMC2-h-scc was concentrated to 15 mg ml1 in 10 mM
Tris–HCl pH 8.0 and 150 mM NaCl. Initial crystallization conditions
were screened by the hanging-drop vapour-diffusion method at 277 K
using the Crystal Screen and Crystal Screen 2 kits from Hampton
Research and the Cryo I and Cryo II kits from Emerald BioSystems.
Crystallization drops were prepared by mixing 1 ml protein solution
(15 mg ml1) and 1 ml reservoir solution and were equilibrated
against 80 ml reservoir solution. Ellipsoid-shaped crystals of hSMC2-
h-scc grew using reservoir solution consisting of 100 mM phosphate–
citrate pH 4.2, 25% 1,2-propanediol, 5% polyethylene glycol 3000
and 10% glycerol (Emerald BioSystems Cryo I condition No. 41)
after one week (Fig. 1a). The crystallization conditions were opti-
mized by varying the precipitant, pH and additives using the sitting-
drop vapour-diffusion method at 277 K. Cube-shaped crystals of
approximately 0.4  0.5  0.3 mm in size were grown from a mixture
of 2 ml protein solution (15 mg ml1) and 3 ml reservoir solution
consisting of 100 mM phosphate–citrate pH 4.5, 24% 1,2-propane-
diol, 10% glycerol and 15 mM NiCl2 after one week (Fig. 1b).
SeMet-substituted hSMC2-h-scc was crystallized using the same
conditions as were optimized for the wild-type hSMC2-h-scc crystals.
The cube-shaped crystals grew to about 0.5  0.5  0.3 mm in size
over two weeks (Fig. 1c). Of the five Leu-to-SeMet mutants, only
Leu68!SeMet crystallized under these conditions. The crystal
morphology was different from those of the wild-type and SeMet-
substituted hSMC2-h-scc crystals; hexagonal-shaped crystals of about
0.3  0.7  0.3 mm in size were obtained after one week (Fig. 1d).
2.3. X-ray diffraction analysis
Prior to data collection, all crystals were retrieved from the droplet
using a nylon loop (Hampton Research) and transferred into a
cryoprotectant solution (reservoir solution containing 10% glycerol)
before being placed directly in a cold nitrogen-gas stream at 100 K.
For wild-type and SeMet-substituted crystals, X-ray diffraction data
were collected using a Rigaku Jupiter 210 CCD detector on beamline
BL38B1 of SPring-8 (Hyogo, Japan). Data from the wild-type crystal
and MAD data from the SeMet-substituted crystal were collected to
resolutions of 2.60 and 3.20 Å, respectively. For the crystals of the
Leu68!SeMet mutant, X-ray diffraction data were collected on the
BL17A beamline of Photon Factory (Tsukuba, Japan) using an
ADSC Quantum 270 CCD detector. SAD data from the crystal of the
Leu68!SeMet mutant were collected to a resolution of 2.42 Å. All
diffraction data were indexed, integrated and scaled with DENZO
and SCALEPACK from the HKL-2000 package (Otwinowski &
Minor, 1997). Data-collection statistics are given in Table 1.
3. Results and discussions
Initially, recombinant proteins consisting of the human SMC2 hinge
domain (Leu492–Glu680) fused to several affinity tags (e.g. His, Trx
and GST) were generated using E. coli expression systems (data not
shown). However, the proteins expressed by these constructs were
unstable and/or insoluble. Therefore, new constructs for the human
SMC2 hinge domain were designed with various lengths of coiled-coil
sequences based on the results of secondary-structure prediction and
homology modelling using the TmSMC hinge-domain structure.
Among the constructs, that encoding the sequence 476–707 with
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Table 1
Data-collection and processing statistics.
Values in parentheses are for the highest resolution shell.
SeMet Leu68!SeMet
Wild type Peak Edge Remote Peak
Crystal data
Space group C222 C222 P3212
Unit-cell parameters
a (Å) 63.5 64.3 64.4 64.4 128.8
b (Å) 86.9 86.8 86.9 86.9 128.8
c (Å) 209.0 212.1 212.2 212.3 91.4
 () 90 90 90 90 90
 () 90 90 90 90 90
 () 90 90 90 90 120
Data collection
Resolution range (Å) 50–2.60 (2.69–2.60) 50–3.20 (3.31–3.20) 19.4–2.42 (2.46–2.42)
Wavelength (Å) 1.00000 0.978726 0.979275 0.964046 0.97898
Measured reflections 120169 69463 68931 68607 367095
Unique reflections 18131 10139 10143 10156 32972
Multiplicity 6.8 (5.3) 6.9 (4.9) 6.8 (4.6) 6.8 (4.7) 11.1 (11.1)
Completeness (%) 97.9 (84.3) 99.6 (96.5) 99.4 (95.2) 98.9 (90.3) 98.4 (91.3)
Mosaicity () 0.774 0.315 0.315 0.313 0.182
Rmerge† 0.077 (0.365) 0.075 (0.392) 0.072 (0.415) 0.076 (0.433) 0.069 (0.395)









i IiðhklÞ, where hI(hkl)i is the average intensity of reflection hkl and symmetry-related reflections.
about 30 residues of predicted coiled-coil region at both ends
(hSMC2-h-scc) was successfully produced as a soluble protein with a
yield of about 30 mg purified protein from 1 l culture.
After several rounds of crystallization screening, cube-shaped
crystals of wild-type hSMC2-h-scc were obtained which diffracted to
2.6 Å resolution (Fig. 1b). However, molecular-replacement methods
using the TmSMC hinge domain as a search model did not produce
interpretable phases. This problem was not solved by the use of SAD
or MAD methods with SeMet-substituted hSMC2-h-scc crystals,
which diffracted to 3.2 Å resolution and had crystallographic para-
meters similar to those of the wild-type crystals (Fig. 1c and Table 1).
The diffraction images of these crystals exhibited significant diffrac-
tion anisotropy and showed relatively high mosaicity. In addition, the
anomalous signal intensities obtained from the SeMet-substituted
crystals were not sufficient for phase determination, suggesting that
the crystal quality was poor and/or the SeMet residues were located
in disordered regions.
To improve crystal quality and locate additional SeMet residues at
better sites for SAD/MAD phasing, several optimization protocols
such as amino-acid substitution methods have been proposed
(Bäckbro et al., 2004). Of these, the substitution of Leu by SeMet was
selected. Based on the results of homology modelling, five Leu resi-
dues were selected that were predicted to be located on the inner part
of the hinge globular domain. Although the Leu31!SeMet mutant
was insoluble, the other mutants Leu66!SeMet, Leu68!SeMet,
Leu74!SeMet and Leu188!SeMet were soluble. Of the four
soluble mutants, only the crystal of the Leu68!SeMet mutant
diffracted well (to a resolution of 2.42 Å with negligible diffraction
anisotropy). The crystal belonged to space group P3212, with two
monomers per asymmetric unit and unit-cell parameters a = b = 128.8,
c = 91.4 Å. The Matthews coefficient was 4.18 Å3 Da1 and the
solvent content of the crystal was calculated to be 70.9% (Matthews,
1968). The space group and unit-cell parameters of the crystal
differed from those of the wild-type and SeMet-substituted hSMC2-
h-scc crystals even though these crystals were obtained using the
same conditions. Furthermore, in contrast to the results from the
SeMet-substituted crystals, which showed poor anomalous signal
intensities, an anomalous difference Patterson map for the Leu68!
SeMet mutant crystals showed very strong peaks corresponding to all
of the Se sites with two molecules in the asymmetric unit, indicating
that the measured anomalous data would be useful in SAD phase
determination. Phase calculations were performed using the
programs SHELXC, SHELXD and SHELXE from the SHELX suite
(Sheldrick, 2008) and the resulting electron-density map was easily
interpretable. Model building and refinement of this model is now in
progress.
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